Evidence map›Paper›PMID 38942893›Full record

ArticleOncogene2024

Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer.

Peter D Haughton, Wisse Haakma, Theofilos Chalkiadakis, Gerben E Breimer, Else Driehuis, Hans Clevers, Stefan Willems, Stefan Prekovic, Patrick W B Derksen

Abstract read
In one paragraph

Article in Oncogene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. [Research and application progress of organoids in head and neck squamous cell carcinoma].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peter D HaughtonDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Wisse HaakmaDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Theofilos ChalkiadakisCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Gerben E BreimerDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Else DriehuisHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, 3584, CT, Utrecht, The Netherlands.
Hans CleversRoche Pharmaceutical Research and Early Development, Basel, Switzerland.ORCID 0000-0002-3077-5582
Stefan WillemsDepartment Pathology and Medical biology, University Medical Center Groningen, Groningen, The Netherlands.
Stefan PrekovicCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. s.prekovic@umcutrecht.nl.ORCID 0000-0002-7051-9321
Patrick W B DerksenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. p.w.b.derksen@umcutrecht.nl.ORCID 0000-0003-0732-7762

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 731957KWF Kankerbestrijding (Dutch Cancer Society) KWF-12045
6 · The paper itself

Abstract

Clinical outcome for patients suffering from HPV-negative head and neck squamous cell carcinoma (HNSCC) remains poor. This is mostly due to highly invasive tumors that cause loco-regional relapses after initial therapeutic intervention and metastatic outgrowth. The molecular pathways governing the detrimental invasive growth modes in HNSCC remain however understudied. Here, we have established HNSCC patient derived organoid (PDO) models that recapitulate 3-dimensional invasion in vitro. Single cell mRNA sequencing was applied to study the differences between non-invasive and invasive conditions, and in a collective versus single cell invading PDO model. Differential expression analysis under invasive conditions in Collagen gels reveals an overall upregulation of a YAP-centered transcriptional program, irrespective of the invasion mode. However, we find that collectively invading HNSCC PDO cells show elevated levels of YAP transcription targets when compared to single cell invasion. Also, collectively invading cells are characterized by increased nuclear translocation of YAP within the invasive strands, which coincides with Collagen-I matrix alignment at the invasive front. Using gene set enrichment analysis, we identify immune cell-like migratory pathways in the single cell invading HNSCC PDO, while collective invasion is characterized by overt upregulation of adhesion and migratory pathways. Lastly, based on clinical head and neck cancer cohorts, we demonstrate that the identified collective invasion signature provides a candidate prognostic platform for survival in HNSCC. By uncoupling collective and single cell invasive programs, we have established invasion signatures that may guide new therapeutic options.

Indexed as

Head and Neck NeoplasmsNeoplasm InvasivenessOrganoidsSquamous Cell Carcinoma of Head and NeckCell Line, TumorCell MovementGene Expression Regulation, NeoplasticHumansPrognosisTranscription FactorsYAP-Signaling ProteinsTranscription FactorsYAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID38942893
PMCPMC11315671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.